The direct binding ELISA of patients' sera has revealed a higher prevalence of autoantibodies in type 2 diabetes mellitus (T2DM, 54%), atherosclerosis (ATH, 33%), and diabetic atherosclerosis (T2DM-ATH, 65%) against MG-Fib. Here, FBL is linked to atherosclerosis.